Importer of Controlled Substances Application: VA Cooperative Studies Program, 33906-33907 [2023-11172]

Download as PDF lotter on DSK11XQN23PROD with NOTICES1 33906 Federal Register / Vol. 88, No. 101 / Thursday, May 25, 2023 / Notices Purpose of the Meeting: The Council agenda will include: INTERNATIONAL TRADE COMMISSION 1. Minutes Review 2. Superintendent Updates will include: General Management Plan 3. Resource Management Updates 4. Subcommittee Reports 5. Old Business 6. New Business 7. Public Comments [Investigation Nos. 701–TA–565 and 731– TA–1341 (Review)] The meeting is open to the public. Interested persons may make oral or written presentations to the Council during the business meeting or file written statements. Requests to address the Council should be made to the Superintendent prior to the meeting. Members of the public may submit written comments by mailing them to Derek Carter (see FOR FURTHER INFORMATION CONTACT). All written comments will be provided to members of the Council. Due to time constraints during the meeting, the Council is not able to read written public comments submitted into the record. Depending on the number of people who wish to speak and the time available, the time for individual comments may be limited. Meeting Accessibility/Special Accommodations: The meeting is open to the public. Please make requests in advance for sign language interpreter services, assistive listening devices, or other reasonable accommodations. We ask that you contact the person listed in the FOR FURTHER INFORMATION CONTACT section of this notice at least seven (7) business days prior to the meeting to give the Department of the Interior sufficient time to process your request. All reasonable accommodation requests are managed on a case-by-case basis. Public Disclosure of Comments: Before including your address, phone number, email address, or other personal identifying information in your comment, you should be aware that your entire comment—including your personal identifying information—may be made publicly available at any time. While you can ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so. Authority: 5 U.S.C. ch. 10. Alma Ripps, Chief, Office of Policy. [FR Doc. 2023–11210 Filed 5–24–23; 8:45 am] BILLING CODE 4312–52–P VerDate Sep<11>2014 18:04 May 24, 2023 Jkt 259001 Hardwood Plywood From China Determination On the basis of the record 1 developed in the subject five-year reviews, the United States International Trade Commission (‘‘Commission’’) determines, pursuant to the Tariff Act of 1930 (‘‘the Act’’), that revocation of the antidumping and countervailing duty orders on hardwood plywood from China would be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time. Background The Commission instituted these reviews on December 1, 2022 (87 FR 73792) and determined on March 6, 2023 that it would conduct expedited reviews (88 FR 19986, April 4, 2023). The Commission made these determinations pursuant to section 751(c) of the Act (19 U.S.C. 1675(c)). It completed and filed its determinations in these reviews on May 19, 2023. The views of the Commission are contained in USITC Publication 5426 (May 2023), entitled Hardwood Plywood from China: Investigation Nos. 701–TA–565 and 731–TA–1341 (Review). By order of the Commission. Issued: May 19, 2023. Lisa Barton, Secretary to the Commission. [FR Doc. 2023–11108 Filed 5–24–23; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. 1196] Importer of Controlled Substances Application: VA Cooperative Studies Program Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: VA Cooperative Studies Program has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. SUMMARY: 1 The record is defined in § 207.2(f) of the Commission’s Rules of Practice and Procedure (19 CFR 207.2(f)). PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before June 26, 2023. Such persons may also file a written request for a hearing on the application on or before June 26, 2023. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on April 12, 2023, VA Cooperative Studies Program, 2401 Centre Avenue SE, Albuquerque, New Mexico 87106, applied to be registered as an importer of the following basic class(es) of controlled substance(s): DATES: Controlled substance Marihuana Extract ........... Tetrahydrocannabinols .... Drug code Schedule 7350 7370 I I The company plans to import finished dosage unit products containing the above listed controlled substances for research and clinical trial studies only. No other activity for this drug code is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug E:\FR\FM\25MYN1.SGM 25MYN1 33907 Federal Register / Vol. 88, No. 101 / Thursday, May 25, 2023 / Notices Administration-approved or nonapproved finished dosage forms for commercial sale. Veranova, L.P. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 24, 2023. Such persons may also file a written request for a hearing on the application on or before July 24, 2023. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for SUMMARY: Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2023–11172 Filed 5–24–23; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1193] Bulk Manufacturer of Controlled Substances Application: Veranova, L.P. Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. In accordance with 21 CFR 1301.33(a), this is notice that on March 27, 2023, Veranova, L.P., 2003 Nolte Drive, West Deptford, New Jersey 08066–1727, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Controlled substance Drug code lotter on DSK11XQN23PROD with NOTICES1 Gamma Hydroxybutyric Acid ......................................................................................................................................... Marihuana ...................................................................................................................................................................... Tetrahydrocannabinols .................................................................................................................................................. Dihydromorphine ............................................................................................................................................................ Difenoxin ........................................................................................................................................................................ Amphetamine ................................................................................................................................................................. Methamphetamine ......................................................................................................................................................... Lisdexamfetamine .......................................................................................................................................................... Methylphenidate ............................................................................................................................................................. Nabilone ......................................................................................................................................................................... 4-Anilino-N-Phenethyl-4-Piperidine (ANPP) .................................................................................................................. Norfentanyl (N-phenyl-N-(piperidin-4-yl) propionamide) ................................................................................................ Cocaine .......................................................................................................................................................................... Codeine .......................................................................................................................................................................... Dihydrocodeine .............................................................................................................................................................. Oxycodone ..................................................................................................................................................................... Dihydromorphine ............................................................................................................................................................ Hydromorphone ............................................................................................................................................................. Diphenoxylate ................................................................................................................................................................ Ecgonine ........................................................................................................................................................................ Hydrocodone .................................................................................................................................................................. Levorphanol ................................................................................................................................................................... Meperidine ..................................................................................................................................................................... Methadone ..................................................................................................................................................................... Methadone intermediate ................................................................................................................................................ Morphine ........................................................................................................................................................................ Thebaine ........................................................................................................................................................................ Opium tincture ............................................................................................................................................................... Oxymorphone ................................................................................................................................................................ Noroxymorphone ........................................................................................................................................................... Alfentanil ........................................................................................................................................................................ Remifentanil ................................................................................................................................................................... Sufentanil ....................................................................................................................................................................... Tapentadol ..................................................................................................................................................................... Fentanyl ......................................................................................................................................................................... The company plans to bulk manufacture the listed controlled substances for the internal use intermediates for sale to its customers. In reference to drug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these 18:04 May 24, 2023 Jkt 259001 PO 00000 I I I I I II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II drug codes are authorized for this registration. Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2023–11169 Filed 5–24–23; 8:45 am] BILLING CODE P VerDate Sep<11>2014 2010 7360 7370 9145 9168 1100 1105 1205 1724 7379 8333 8366 9041 9050 9120 9143 9145 9150 9170 9180 9193 9220 9230 9250 9254 9300 9333 9630 9652 9668 9737 9739 9740 9780 9801 Schedule Frm 00048 Fmt 4703 Sfmt 9990 E:\FR\FM\25MYN1.SGM 25MYN1

Agencies

[Federal Register Volume 88, Number 101 (Thursday, May 25, 2023)]
[Notices]
[Pages 33906-33907]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-11172]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. 1196]


Importer of Controlled Substances Application: VA Cooperative 
Studies Program

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: VA Cooperative Studies Program has applied to be registered as 
an importer of basic class(es) of controlled substance(s). Refer to 
SUPPLEMENTARY INFORMATION listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
June 26, 2023. Such persons may also file a written request for a 
hearing on the application on or before June 26, 2023.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment. All 
requests for a hearing must be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152. All requests for a hearing should also be 
sent to: Drug Enforcement Administration, Attn: Administrator, 8701 
Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on April 12, 2023, VA Cooperative Studies Program, 2401 
Centre Avenue SE, Albuquerque, New Mexico 87106, applied to be 
registered as an importer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Marihuana Extract.......................    7350  I
Tetrahydrocannabinols...................    7370  I
------------------------------------------------------------------------

    The company plans to import finished dosage unit products 
containing the above listed controlled substances for research and 
clinical trial studies only. No other activity for this drug code is 
authorized for this registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug

[[Page 33907]]

Administration-approved or non-approved finished dosage forms for 
commercial sale.

Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-11172 Filed 5-24-23; 8:45 am]
BILLING CODE P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.